Company updates
Registrations, capacity, quality system and facility news, published as it happens.
Facility areas (2,040.87 m² total, 507.8 m² cleanroom), licensed scope, quality system, capacity figures and the 2025–2030 roadmap are now documented in a single partner deck. The website has been updated to match it.
Ten type-test reports covering electrical safety, electromagnetic compatibility, puncture force, cooling flow, VSWR and EO residue are indexed for customer evaluation, with report numbers and testing laboratories listed. Full reports are available on request under NDA.
Version 1.0 documents the 18 registered needle configurations, mechanical and microwave performance limits, materials, EO sterilisation and the registration summary (国械注准20253010071).
Anchor and coil configurations of the localization needle (苏械注准20242021492) are documented with capacity of 40,000 units a year. The registration certificate of the single-use radiofrequency ablation electrode (赣械注准20242010142) is now published on the certificates page.
Certificate 国械注准20253010071 was issued to the registration holder for the single-use microwave ablation needle, indicated for solid liver tumours and benign thyroid nodules. The certificate is valid until 9 January 2030; production runs on our line.
Nanjing Jinghang Guoye Medical Technology Co., Ltd. was established on 14 October 2024 as a contract manufacturing platform for high-end minimally invasive interventional devices.
